龙8国际唯一授权_龙8国际娱乐注册_龙8国际是什么

2000 WuXi AppTec Ltd., was established in WuXi, Jiangsu, the PRC
2001 Established services in synthetic chemistry
2003 Manufacturing process development
2004 Research manufacturing
2005 Bioanalytical services
2006 Service biology
2007
Toxicology and formulation
WXAT Suzhou became the first company in China to earn accreditation form the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and Good Laboratory Practice (GLP) from the Organization for Economic Co-operation and Development (OECD)
2008 WuXi PharmaTech acquired AppTec Laboratory Services, Inc., a U.S
2009 Opened a toxicology facility in Suzhou
2010 Opened a large-scale manufacturing facility in Jinshan
2011
Further expanded to clinical development and registration
Acquired Medkey, and Abgent
2012 Opened another chemistry facility in Wuhan and a research center in WuXi
2013 STA successfully earned accreditation from FDA
2014
Setting up branch office in Israel, Boston and San Francisco in the U.S. 
Acquired XenoBiotic Laboratories, Inc., 
2015
Shares of STA were quoted on the NEEQ (stock code: 832159)
Established laboratory testing division to provide services on medical device testing
2016
STA opened new facilities in Changzhou and operations in San Diego
Acquired Crelux GmbH in Munich, Germany
2017 Acquired HD Biosciences (Shanghai) Co., Ltd.
2018 Listed on the SSE (stock code: 603259)